<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4485">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04374643</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0197</org_study_id>
    <nct_id>NCT04374643</nct_id>
  </id_info>
  <brief_title>Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population</brief_title>
  <acronym>PsyConfPop</acronym>
  <official_title>Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population : PsyConfPop</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Quarantine is an unpleasant experience : separation from loved ones, loss of freedom,&#xD;
      uncertainty about infection status, boredom. It may lead to negative mental health&#xD;
      consequences and thus the emergence of anxiety and depressive symptoms.&#xD;
&#xD;
      From March 17th, 2020 to May 11th 2002, the French government has implemented national&#xD;
      containment measures due to the Covid-19 epidemic.&#xD;
&#xD;
      Although there are data on the psychological impact and experience of quarantine measures in&#xD;
      people who have been infected or suspected of being carriers of certain pathogens (e.g.&#xD;
      Ebola), there are no data on such impact in the French population and quarantines lasting&#xD;
      longer than 21 days. Investigators therefore propose to conduct a human and social sciences&#xD;
      study in order to better understand the current situation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to describe the psychological state during confinement (and the impact&#xD;
      of the confinement) in a sample of the French general population.&#xD;
&#xD;
      Secondary objectives :&#xD;
&#xD;
        -  to assess the evolution of psychological health between the period of confinement and&#xD;
           post-confinement.&#xD;
&#xD;
        -  to identify clinical factors modulating psychological state during confinement&#xD;
&#xD;
      It is expected to highlight :&#xD;
&#xD;
        -  a link between the intensity of anxiety symptoms and the number/quality of social&#xD;
           contacts&#xD;
&#xD;
        -  a reduction of anxiety and depression symptoms in the post-confinement period.&#xD;
&#xD;
        -  higher consumption of drugs during the confinement period&#xD;
&#xD;
      Self-questionnaires (Google form format) are sent by mailing lists or social networks to&#xD;
      participants in order to complete the assessment of psychological state. A unique identifier&#xD;
      is sent in a separate email. These assessments are performed at least once during the&#xD;
      confinement period. It is planned to repeat them when the confinement is lifted: 15 days, 3&#xD;
      and 6 months after the lifting of the confinement because of the risk of developing&#xD;
      anxiodepressive symptoms, in particular post-traumatic stressors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Depressive Symptomatology</measure>
    <time_frame>during confinement</time_frame>
    <description>depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -&gt; min : 0 max : 27)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depressive Symptomatology</measure>
    <time_frame>post-confinement : 15 days, 3 months, 6 months</time_frame>
    <description>depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -&gt; min : 0 max : 27)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Psychological pain</measure>
    <time_frame>during confinement</time_frame>
    <description>Psychological pain : likert scale (higher score, more psychological pain-&gt; min : 0 max : 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>sleep</measure>
    <time_frame>during confinement</time_frame>
    <description>quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia -&gt; min : 0 max : 28)</description>
  </other_outcome>
  <other_outcome>
    <measure>sleep</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia -&gt; min : 0 max : 28)</description>
  </other_outcome>
  <other_outcome>
    <measure>anxiety</measure>
    <time_frame>during confinement</time_frame>
    <description>anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious -&gt; min : 0 max : 21)</description>
  </other_outcome>
  <other_outcome>
    <measure>anxiety</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious -&gt; min : 0 max : 21)</description>
  </other_outcome>
  <other_outcome>
    <measure>psychological pain</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>psychological pain : likert scale (higher score, more psychological pain-&gt; min : 0 max : 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>physical pain</measure>
    <time_frame>during confinement</time_frame>
    <description>psychological pain : likert scale (higher score, more psychological pain-&gt; min : 0 max : 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>physical pain</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>psychological pain : likert scale higher score, more psychological pain-&gt; min : 0 max : 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>anger</measure>
    <time_frame>during confinement</time_frame>
    <description>staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger -&gt; min : 0 max : 50)</description>
  </other_outcome>
  <other_outcome>
    <measure>anger</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger -&gt; min : 0 max : 50)</description>
  </other_outcome>
  <other_outcome>
    <measure>Stressful Event Impact</measure>
    <time_frame>during confinement</time_frame>
    <description>Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes -&gt; min : 0 max : 45)&#xD;
)</description>
  </other_outcome>
  <other_outcome>
    <measure>Stressful Event Impact</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes -&gt; min : 0 max : 45)</description>
  </other_outcome>
  <other_outcome>
    <measure>Use of psychotropic drugs</measure>
    <time_frame>during confinement</time_frame>
    <description>Number of patients declaring an increase of psychotropic drug use</description>
  </other_outcome>
  <other_outcome>
    <measure>Use of psychotropic drugs</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Number of patients declaring an increase of psychotropic drug use</description>
  </other_outcome>
  <other_outcome>
    <measure>Tobacco consumption</measure>
    <time_frame>during confinement</time_frame>
    <description>Number of patients declaring an increase of tobacco consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>Tobacco consumption</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Number of patients declaring an increase of tobacco consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>alcohol consumption</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Number of patients declaring an increase of alcohol consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>alcohol consumption</measure>
    <time_frame>confinement</time_frame>
    <description>Number of patients declaring an increase of alcohol consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>Illicit substances consumption</measure>
    <time_frame>confinement</time_frame>
    <description>Number of patients declaring an increase of illicit substances consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>Illicit substances consumption</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Number of patients declaring an increase of illicit substances consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>orientation of life</measure>
    <time_frame>confinement</time_frame>
    <description>Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --&gt; min : 0 max : 24</description>
  </other_outcome>
  <other_outcome>
    <measure>orientation of life</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --&gt; min : 0 max : 24</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Depression</condition>
  <condition>COVID 19</condition>
  <arm_group>
    <arm_group_label>Confined patients</arm_group_label>
    <description>General population</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Slef questionnaires fulfilment</intervention_name>
    <description>Questionnaires to assess the psychological impact of confinement and its evolution over 6 months</description>
    <arm_group_label>Confined patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults who agree to participate by answering the questionnaires&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
        - age&gt; 18&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - protective measure (curatorship, guardianship)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emilie Olie, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emilie Olie, MD PhD</last_name>
    <phone>+33 4 67 33 85 81</phone>
    <email>e-olie@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Genty, MD</last_name>
      <phone>+33 4 67 99 61 45 75</phone>
      <email>c-genty@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2020</study_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Confinement</keyword>
  <keyword>Depression</keyword>
  <keyword>Post traumatic stress</keyword>
  <keyword>Adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

